58 related articles for article (PubMed ID: 17643815)
1. FANCD2 depletion sensitizes cancer cells repopulation ability in vitro.
Lyakhovich A; Surralles J
Cancer Lett; 2007 Oct; 256(2):186-95. PubMed ID: 17643815
[TBL] [Abstract][Full Text] [Related]
2. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the FA/BRCA pathway in bladder cancer.
Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
[TBL] [Abstract][Full Text] [Related]
4. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA (siRNA) inhibited human liver cancer cell line SMMC7721 proliferation and tumorigenesis.
Dong-Dong L
Hepatogastroenterology; 2007 Sep; 54(78):1731-5. PubMed ID: 18019706
[TBL] [Abstract][Full Text] [Related]
6. The role of T-fimbrin in the response to DNA damage: silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents.
Ikeda H; Sasaki Y; Kobayashi T; Suzuki H; Mita H; Toyota M; Itoh F; Shinomura Y; Tokino T; Imai K
Int J Oncol; 2005 Oct; 27(4):933-40. PubMed ID: 16142308
[TBL] [Abstract][Full Text] [Related]
7. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
8. The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage.
Dequen F; St-Laurent JF; Gagnon SN; Carreau M; Desnoyers S
Comp Biochem Physiol B Biochem Mol Biol; 2005 Aug; 141(4):453-60. PubMed ID: 15979372
[TBL] [Abstract][Full Text] [Related]
9. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
Zhang SC; Qiao L; Gao H
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
11. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.
Gallmeier E; Calhoun ES; Rago C; Brody JR; Cunningham SC; Hucl T; Gorospe M; Kohli M; Lengauer C; Kern SE
Gastroenterology; 2006 Jun; 130(7):2145-54. PubMed ID: 16762635
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of
Komatsu H; Masuda T; Iguchi T; Nambara S; Sato K; Hu Q; Hirata H; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Anticancer Res; 2017 Mar; 37(3):1083-1090. PubMed ID: 28314268
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
16. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP
Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
[TBL] [Abstract][Full Text] [Related]
17. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
Tsuchida K; Komatsu K
Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
[TBL] [Abstract][Full Text] [Related]
18. FANCD2 knockdown with shRNA interference enhances the ionizing radiation sensitivity of nasopharyngeal carcinoma CNE-2 cells.
Bao Y; Feng H; Zhao F; Zhang L; Xu S; Zhang C; Zhao C; Qin G
Neoplasma; 2021 Jan; 68(1):40-52. PubMed ID: 32940045
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
20. Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin.
Fechner G; Pocha K; Schmidt D; Müller SC
Int J Clin Pract; 2006 Oct; 60(10):1178-80. PubMed ID: 16669821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
